Objective:To investigate the application value of ERAS in the standardized diagnosis and treatment of senile osteoporotic hip fracture.Methods:From June 2016 to June 2018, 458 cases of elderly patients with osteoporotic hip fracture received surgical treatment were selected.Model group according to the diagnosis and treatment, which USES the ERAS diagnostic model is incorporated into research group (229 cases), the others all routine practice mode, with 1:1 the adjacent propensity score matching (PSM) in patients with routine practice mode to filter, make out the object of study in clinical baseline characteristics were comparable with ERAS group, incorporated in the control group (229 cases).Postoperative VAS scores and Harris scores of hip joint function were compared between the two groups.The incidence of complications, time from admission to operation, length of stay, hospitalization costs, readmission rate and mortality rate within 12 months after operation were recorded.Results:The VAS scores of the study group were (3.01±1.25), (2.04±1.08) and (1.51±0.82) on the first, third and fifth days after the operation, which were lower than those of the control group (4.11±1.32), (3.86±1.16) and (3.22±1.28) (P<0.05);The time from admission to operation and the time of hospitalization in the study group were (45.21±10.25) h and (8.95±1.22) d, respectively, which were shorter than (122.05±19.54) h and (12.21±1.42) d in the control group (P<0.05);The hospitalization cost of the study group was (31309.58±18096.42) yuan, which was less than that of the control group (35879.72±17814.31) yuan (P<0.05);The incidence of postoperative complications in the study group (3.93%) was lower than that in the control group (13.10%) (P<0.05);One month after the operation, the Harris score of the study group was (90.70±2.44), which was higher than that of the control group (81.40±5.43) (P<0.05);After 12 months of follow-up, the readmission rate and mortality rate of the study group were 2.18% and 0.87%, respectively, lower than that of the control group (6.55% and 3.93%) (P<0.05).Conclusion:The use of ERAS standardized treatment model to treat senile osteoporosis hip fracture can relieve postoperative pain, promote recovery, reduce economic burden, prevent related complications, improve hip function, and reduce early readmission rate and mortality.